This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Maximizing The Effectiveness Of Market Research Groups Through Outsourcing And Automation

CHAPEL HILL, N.C., Jan. 17, 2013 /PRNewswire/ -- Market research executives in the healthcare sector need to continually evaluate the need for outsourced personnel. In the dynamic biopharmaceutical marketplace, cost-saving tactics such as outsourcing and automation can enhance efficiency and maintain performance across different functions, including market research.

A recent study by research and consulting firm Best Practices, LLC found that while the need for externally contracted labor varies widely among biopharma companies, outsourcing personnel for primary research is the most common need among market research leaders. A majority of companies in the study also have been successful in implementing the use of automation into their market research operation.

"Market Research Efficiency Benchmark: Using External Personnel and Automation to Maximize Effectiveness" is a new report that pinpoints innovative approaches and strategies for increasing efficiency through the use of automation and outsourced labor in market research groups.

Issues addressed in the study include:

  • Maximizing efficiency and maintaining a lean internal headcount in the face of increased workload
  • Automate market research processes for efficient report generation and better knowledge management
  • Methods used to implement and manage automated systems

The research also examines best practices in relation to the type and quantity of outsourcing used by market research leaders at leading biopharmaceutical companies.

More than 50% of all respondents predicted no change or even reductions in internal staffing levels in the next two years. Leaders burdened with headcount constraints can gain critical insights from this study that will help them maintain an effective, efficient market research group through the use of outsourced labor and automation.

This benchmarking research project drew participation from 22 market research executives from 19 different pharmaceutical and medical device companies. In addition, deep-dive interviews were conducted with seven participating industry veterans to gather additional insights.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,164.95 -251.90 -1.45%
S&P 500 1,994.99 -26.26 -1.30%
NASDAQ 4,635.24 -48.1670 -1.03%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs